Cigarette smoking, N-acetyltransferase genes and the risk of advanced colorectal adenoma

被引:43
作者
Moslehi, Roxana
Chatterjee, Nilanjan
Church, Timothy R.
Chen, Jinbo
Yeager, Meredith
Weissfeld, Joel
Hein, David W.
Hayes, Richard B.
机构
[1] NCI, Div Canc Epidemiol & Genet, NIH, Rockville, MD 20852 USA
[2] Univ Pittsburgh, Pittsburgh, PA 15260 USA
[3] Natl Canc Inst, Core Genotyping Facil, Ctr Adv Technol, Frederick, MD USA
[4] Univ Minnesota, Minneapolis, MN 55455 USA
[5] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA
[6] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA
关键词
cancer precursor; cigarette smoking; colorectal adenoma; N-acetyltransferases; NATI; NAT2;
D O I
10.2217/14622416.7.6.819
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Cigarette use is associated with greater risk for colorectal adenoma, a colorectal cancer precursor. N-acetyltransf erases, NAT1 and NAT2, are important enzymes involved in the metabolism of aromatic amine carcinogens present in cigarette smoke. Our interest is in the polymorphisms within the NAT1 and NAT2 genes that influence the tobacco-colorectal tumor relationship by impacting on the metabolic activation and cletoxification of tobacco smoke-derived carcinogens. Methods: In the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial, we compared NAT1 and NAT2 gene variant distributions for 772 cases with left-sided advanced adenoma and 777 gender and age-matched controls. Individual NAT1 and NAT2 diplotypes were assigned and NAT2 acetylator phenotypes were derived. Results: Risks for advanced colorectal adenoma were significantly increased among recent smokers (current smokers or those who quit less than 10 years ago) (odds ratio [OR] = 2.3, 95% confidence interval [Cl]: 1.7-3.1) and among those who smoked more than 20 cigarettes per day (OR = 1.7, 95% Cl: 1.3-2.2), compared with nonsmokers. Risk decreased with increasing NAT2 phenotypic activity (0: slow, 1: intermediate, and 2: rapid) (OR trend: 0.8; 95% Cl: 0.7-1.0, p-trend = 0.04) overall. When stratified by smoking status, significant phenotype-associated trends were observed among recent smokers (OR trend = 0.4, 95% Cl: 0.3-0.7, p trend < 0.001) (p-interaction = 0.02), but not among past or nonsmokers. Diplotypes most strongly associated with lower risks in smokers were NAT2*4/*5B (OR = 0.3, 95% Cl: 0.1-0.8, p = 0.01) and NAT2*4/*4 (OR = 0.2, 95% Cl: 0.04-0.7, p = 0.02), categorized as intermediate and rapid acetylators, respectively. One NAT1 diplotype, NAT1*4/*10 (OR = 0.5, 95% Cl: 0.3-0.9, p = 0.03), was also associated with a decreased risk in smokers. Conclusions: Our study indicated that NAT2 gene variants associated with a slow acetylator phenotype were more susceptible to the effects of tobacco smoking with respect to adenoma risk, providing leads for disease prevention.
引用
收藏
页码:819 / 829
页数:11
相关论文
共 39 条
[21]   ROLE OF AROMATIC AMINE ACETYLTRANSFERASE IN HUMAN COLORECTAL-CANCER [J].
LANG, NP ;
CHU, DZJ ;
HUNTER, CF ;
KENDALL, DC ;
FLAMMANG, TJ ;
KADLUBAR, FF .
ARCHIVES OF SURGERY, 1986, 121 (11) :1259-1261
[22]   Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption [J].
Lilla, C ;
Verla-Tebit, E ;
Risch, A ;
Jäger, B ;
Hoffmeister, M ;
Brenner, H ;
Chang-Claude, J .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (01) :99-107
[23]   Variants of N-acetyltransferase NAT1 and a case-control study of colorectal adenomas [J].
Lin, HJ ;
Probst-Hensch, NM ;
Hughes, NC ;
Sakamoto, GT ;
Louie, AD ;
Kau, IH ;
Lin, BK ;
Lee, DB ;
Lin, J ;
Frankl, HD ;
Lee, ER ;
Hardy, S ;
Grant, DM ;
Haile, RW .
PHARMACOGENETICS, 1998, 8 (03) :269-281
[24]  
MARTINI BD, 2004, TOBACCO INDUCED DIS, V2, P51
[25]   Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma [J].
Morton, Lindsay M. ;
Schenk, Maryjean ;
Hein, David W. ;
Davis, Scott ;
Zahm, Shelia Hoar ;
Cozen, Wendy ;
Cerhan, James R. ;
Hartge, Patricia ;
Welch, Robert ;
Chanock, Stephen J. ;
Rothman, Nathaniel ;
Wang, Sophia S. .
PHARMACOGENETICS AND GENOMICS, 2006, 16 (08) :537-545
[26]   Acetylator phenotype and genotype in patients infected with HIV: discordance between methods for phenotype determination and genotype [J].
O'Neil, WM ;
Drobitch, RK ;
MacAruthur, RD ;
Farrough, MJ ;
Doll, MA ;
Fretland, AJ ;
Heine, DW ;
Crane, LR ;
Svensson, CK .
PHARMACOGENETICS, 2000, 10 (02) :171-182
[27]  
Potter JD, 1999, CANCER EPIDEM BIOMAR, V8, P69
[28]  
PROBSTHENSCH NM, 1995, CANCER RES, V55, P2017
[29]   Lack of association between the polyadenylation polymorphism in the NAT1 (acetyltransferase 1) gene and colorectal adenomas [J].
ProbstHensch, NM ;
Haile, RW ;
Li, DS ;
Sakamoto, GT ;
Louie, AD ;
Lin, BK ;
Frankl, HD ;
Lee, ER ;
Lin, HJ .
CARCINOGENESIS, 1996, 17 (10) :2125-2129
[30]   Surveillance after positive and negative colonoscopy examinations: Issues, yields, and use [J].
Schoen, RE .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (06) :1237-1246